SCHEMBL7018017

SCHEMBL7018017

CCOc1nc2cccc(C(=O)OC)c2n1Cc1ccc(-c2ccccc2C(N)=O)cc1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.59
AGTR2 P50052 3/20 0.59
CYP3A4 P08684 2/20 0.59
ADORA3 P0DMS8 2/20 0.59
ADRA2B P18089 2/20 0.59
SLC6A2 P23975 2/20 0.59
AGTR1 P30556 2/20 0.59
HTR2B P41595 2/20 0.59
PDE3A Q14432 2/20 0.59
ABCB11 O95342 1/20 0.59
EGFR P00533 1/20 0.59
ERBB2 P04626 1/20 0.59
CYP2C9 P11712 1/20 0.59
ADRB3 P13945 1/20 0.59
TBXAS1 P24557 1/20 0.59
HTR2C P28335 1/20 0.59
LTB4R2 Q9NPC1 1/20 0.59
NAE1 Q13564 2/20 0.49
KDM4E B2RXH2 1/20 0.49
MEN1 O00255 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30206864 1.00 PPARG (0.59) PPARGAGTR2CYP3A4ADORA3ADRA2B
SCHEMBL3977106 0.94 AGTR2 (0.62) PPARGAGTR2CYP3A4ADORA3ADRA2B
SCHEMBL13465074 0.93 AGTR2 (0.59) PPARGAGTR2CYP3A4ADORA3ADRA2B
SCHEMBL17424354 0.91 AGTR2 (0.55) PPARGAGTR2CYP3A4ADORA3ADRA2B
SCHEMBL15157487 0.91 AGTR2 (0.55) PPARGAGTR2CYP3A4ADORA3ADRA2B
SCHEMBL16367902 0.91 AGTR2 (0.55) PPARGAGTR2CYP3A4ADORA3ADRA2B
SCHEMBL8642706 0.91 AGTR1 (0.53) PPARGAGTR2CYP3A4ADORA3ADRA2B
SCHEMBL15157485 0.91 AGTR2 (0.55) PPARGAGTR2CYP3A4ADORA3ADRA2B
SCHEMBL21168140 0.91 AGTR2 (0.59) PPARGAGTR2CYP3A4ADORA3ADRA2B
SCHEMBL31364599 0.90 PPARG (0.70) PPARGAGTR2CYP3A4ADORA3ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9233955-B2 Process for the preparation of azilsartan medoxomil JUBILANT LIFE SCIENCES, LTD. (IN) 2016-01-12 US disclosed
EP-0520423-B1 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2003-05-14 EP disclosed
US-6100252-A SPECIFIED COMPOUNDS INCLUDING METHYL 2-BUTYL-1-((2'-(2-OXO-3H-1,2,3,5-OXATHIADIAZOL-4-YL)BIPHENYL) METHYL)-BENZIMIDAZOLE-7-CARBOXYLATE; USE TO TREAT CIRCULATORY DISEASES SUCH AS HYPERTENSIVE DISEASES AND HEART DISEASES TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-08-08 US disclosed
US-5883111-A STRONG AND LONG-LASTING ACTION BY ORAL ADMINISTRATION; HYPOTENSIVE AGENTS; CARDIOTONIC AGENTS; ALZHEIMER'S DISEASE; TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1999-03-16 US disclosed
US-5583141-A ADMINISTERING AS THERAPEUTIC AGENTS OF CIRCULATORY DISEASES; AZILSARTAN; ANGIOTENSIN II ANTAGONISTS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1996-12-10 US disclosed
US-5354766-A 2-Ethoxy-1-((2'(2,5-dihydro-5-oxo-1,2,4-oxadiazol-3-yl) biphenyl-4-yl)methyl)benzimidazole-7-carboxylic acid; hypotensive agents; CNS activity TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1994-10-11 US disclosed
US-5243054-A Hypotensive agents, cardiovascular disorders or nervous system disorders TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1993-09-07 US disclosed
EP-0520423-A2 Heterocyclic compounds, their production and use as angiotensin II antagonists TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1992-12-30 EP disclosed